Updated on 16 April 2012
Malaysia's InnoBiologics Biopharmaceutical is in a 10-year collaboration agreement with Boehringer Ingelheim for biologics manufacturing since 2009. InnoBio has a manufacturing facility for mammalian cell-based expression system (200 L and 1,000 L) and it is certified as compliant to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (jointly referred to as PIC/S). They are two international instruments between countries and pharmaceutical inspection authorities that provide an active and constructive co-operation in the field of GMP.
The company believes that InnoBiologics and Boehringer Ingelheim's smart partnerships ensure effective capacity utilization and smooth technology transfer for customers who decide to transfer production to big contract manufacturing organizations for large-scale production.